Cibc Private Wealth Group, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,000 shares of ARWR stock, worth $16,570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$16,570
Previous $18,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ARWR
# of Institutions
300Shares Held
98MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$260 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$219 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$184 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$116 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$86.7 Million1.32% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.75B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...